The disease severity index for inflammatory bowel disease is associated with psychological symptoms
The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a...
top of page
The Mission
Key Opinion Leaders
International
Advisory Board
Initiatives
Discuss a case
Journal Scan
Latest News
Education Hub
Gallery
IBDENC ENC
- Jun 9, 2022
PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis
PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring...
IBDENC ENC
- May 21, 2022
Real-world multicentre observational study including population pharmacokinetic modelling
Real-world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure–response relationship...
IBDENC ENC
- May 19, 2022
The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients
Carlos G Gonzalez, Robert H Mills, Melissa C Kordahi, Marvic Carrillo-Terrazas, Henry Secaira-Morocho, Christella E Widjaja, Matthew S...
IBDENC ENC
- May 16, 2022
A systems genomics approach to uncover patient-specific pathogenic pathways and proteins
A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis. Johanne Brooks-Warburton,...
IBDENC ENC
- May 14, 2022
TM9SF4 Is a Crucial Regulator of Inflammation and ER Stress in Inflammatory Bowel Disease
Mingxu Xie, Joyce Wing Yan Mak, Hongyan Yu, Cherry Tsz Yan Cheng, Heyson Chi Hey Chan, Ting Ting Chan, Louis Ho Shing Lau, Marc Ting Long...
IBDENC ENC
- May 11, 2022
Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-α therapy in patients
Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-α therapy in patients with inflammatory bowel diseases....
IBDENC ENC
- May 7, 2022
Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients
Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease. Viktoria...
IBDENC ENC
- May 3, 2022
Age determines the risk of familial inflammatory bowel disease - A nationwide study
Jonas Halfvarson, Jonas F Ludvigsson, Francesca Bresso, Johan Askling, Michael C Sachs, Ola Olén Published in April 2022, Alimentary...
IBDENC ENC
- Apr 29, 2022
Use of biologics and small molecule drugs for the management of moderate to severe UC
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD technical review based on...
IBDENC ENC
- Apr 29, 2022
Polypharmacy in Patients with Inflammatory Bowel Disease: Prevalence and Outcomes
Polypharmacy in Patients with Inflammatory Bowel Disease: Prevalence and Outcomes in a Single-center Series Francisco Mesonero, Cristina...
IBDENC ENC
- Apr 22, 2022
Decreased serum iron concentration and total iron binding capacity are associated
Decreased serum iron concentration and total iron binding capacity are associated with serious Crohn’s disease Jingling Su, Yandan Ren,...
bottom of page